OBJECTIVE:
To determine whether clinical and biochemical features of Graves' disease at presentation predict response to medical and radioiodine treatment.
METHODS:
We carried out a retrospective 10-year study of 194 consecutive Saudi subjects with Graves' disease who were treated with antithyroid drugs, radioiodine therapy, or both, between January 1995 and December 2004 at King Khalid University Hospital, Riyadh, Saudi Arabia.
RESULTS: